AU2000243657A1 - Method of binding integrin for treatment of cancer - Google Patents

Method of binding integrin for treatment of cancer

Info

Publication number
AU2000243657A1
AU2000243657A1 AU2000243657A AU4365700A AU2000243657A1 AU 2000243657 A1 AU2000243657 A1 AU 2000243657A1 AU 2000243657 A AU2000243657 A AU 2000243657A AU 4365700 A AU4365700 A AU 4365700A AU 2000243657 A1 AU2000243657 A1 AU 2000243657A1
Authority
AU
Australia
Prior art keywords
cancer
treatment
binding integrin
integrin
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000243657A
Inventor
Michael J. Manyak
Steven R. Patierno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
George Washington University
Original Assignee
George Washington University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Washington University filed Critical George Washington University
Publication of AU2000243657A1 publication Critical patent/AU2000243657A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2000243657A 2000-04-21 2000-04-21 Method of binding integrin for treatment of cancer Abandoned AU2000243657A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/010713 WO2001080872A1 (en) 2000-04-21 2000-04-21 Method of binding integrin for treatment of cancer

Publications (1)

Publication Number Publication Date
AU2000243657A1 true AU2000243657A1 (en) 2001-11-07

Family

ID=21741300

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000243657A Abandoned AU2000243657A1 (en) 2000-04-21 2000-04-21 Method of binding integrin for treatment of cancer

Country Status (2)

Country Link
AU (1) AU2000243657A1 (en)
WO (1) WO2001080872A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0402536D0 (en) * 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2078817A1 (en) * 1991-10-18 1993-04-19 Beat A. Imhof Anti-.alpha.6-integrin-antibodies
US5696092A (en) * 1995-03-07 1997-12-09 George Washington University Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers
US5935860A (en) * 1995-03-07 1999-08-10 The George Washington University Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
US20020160948A1 (en) * 1998-07-21 2002-10-31 Aprile Pilon Recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

Also Published As

Publication number Publication date
WO2001080872A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
AU2001227966A1 (en) Methods for treating tumors
AU2001255602A1 (en) Methods for treating bone tumors
AU2001231104A1 (en) Methods for treating diabetes
AU2002215125A1 (en) Well treatment method
AU2003226301A1 (en) Method of treating cancer
AU2002328952A1 (en) Irinotecan for treatment of cancer
AU2002303283A1 (en) Methods for treating drug addiction
AU2003256847A1 (en) Method of treating cancer
AU2001245751A1 (en) Method and device for skin cancer screening
EP1176964B8 (en) Uses of et743 for treating cancer
AU4063600A (en) A method of treating cancer
AU2001268467A1 (en) Identification of genes and compounds for treatment of cancer
AU2001286983A1 (en) Method of treatment
AUPR152100A0 (en) Method for treating coral
AU2001240046A1 (en) Method of treating skin conditions
AU2001232263A1 (en) Method of treating seeds
AU2001253836A1 (en) Method of treating cancer
AU2002308642A1 (en) Methods for treating cancer
AU7363000A (en) Method for reducing the risk of cancer
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU2001241779A1 (en) Method of treatment of prostate cancer
AU2001238179A1 (en) Method and compositions for treating hepatocellular cancer
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2001262177A1 (en) Method of treatment